Dogwood Therapeutics Secures $100M Partnership for Antiviral Assets
Alpharetta, Georgia, USA – April 23, 2026 Dogwood Therapeutics announced a global development and commercialization partnership with PRIDCor Therapeutics...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
Alpharetta, Georgia, USA – April 23, 2026 Dogwood Therapeutics announced a global development and commercialization partnership with PRIDCor Therapeutics...
MENLO PARK, CA — November 20, 2025 — Antheia announced a strategic partnership with TAPI (Teva Active Pharmaceutical Ingredients)...
Dateline – November 17, 2025 | San Jose, California Anixa Biosciences, Inc. announced that the WHO’s International Non-proprietary Names...
Dateline – November 17, 2025 | Bengaluru, India In a significant development for India’s pharmaceutical ecosystem, AstraZeneca Pharma India...
Andelyn Biosciences, a leading cell and gene therapy CDMO, has partnered with Tern Therapeutics to perform late-stage Process Performance...
